Onconetix Inc

Onconetix insider trades reveal HRT Financial’s bullish stance amid volatile share price and ONC010’s clinical progress—an insider‑insight into biotech growth prospects.

HRT’s bulk buy of Onconetix shares signals insider confidence amid a sharp price drop, hinting at potential clinical or partnership wins that could unlock value for investors.